OxSyBio Raises $1.7 Million to Develop Synthetic 3D Printed Tissues For Organ and Skin Repairs
A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term the company aims to print synthetic tissues for organ repair or replacement.
Isis Innovation, the University’s research commercialisation company announced today that OxSyBio has raised £1 million from IP Group plc, the developer of intellectual property based businesses, subject to the achievement of milestones. The new company will refine and advance the 3D droplet printing technology devised by Professor Hagan Bayley’s group at the University’s Department of Chemistry.